Lymphocyte subsets in peripheral blood as prognostic factors in colorectal cancer

Journal of B.U.ON.

Volumn 10, Issue 2, 2005, Pages 261-264

  Milasiene, V ^a   Stratilatovas, Eugenijus ^a   Norkiene, V ^a   Jonusauskaite, R ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Colorectal cancer; Lymphocytes subsets; Prognostic factors; Surgery; Survival

Indexed keywords

CD16 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; CANCER STAGING; CANCER SURVIVAL; CELLULAR IMMUNITY; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; FEMALE; HELPER CELL; HEMOGLOBIN DETERMINATION; HEPARINIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE STATUS; IMMUNOFLUORESCENCE; IMMUNOREGULATION; LEUKOCYTE COUNT; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; MONOCYTE; NATURAL KILLER CELL; PREOPERATIVE EVALUATION; PROGNOSIS; REGRESSION ANALYSIS; SURGICAL TECHNIQUE; THROMBOCYTE;

EID: 24944447713     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Satia JA, Campbell MK, Galanko JA. Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarcers Prev 2004; 13: 1022-1031.
2. Kiessling R, Wasserman K, Horiguchi S et al. Tumor-induced immune dysfunction. Cancer Immunol Immunother 1999; 48: 353-362.
3. Martinez ME, Hennig SM, Alberts DS. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutrition 2004; 79: 691-697.
4. O'Byrne KJ, Dalgleish AG, Browning MJ et al. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 2000; 36: 151-169.
5. Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease. Curr Res Head Neck Cancer 2005; 62: 161-172.
6. Foss FM. Immunologic mechanisms of antitumor activity. Semin Oncol 2002; 29: 5-11.
7. Heriot AG, Marriott JB, Cookson S, Kumar D, Dalgleish AG. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection. Br J Cancer 2000; 82: 1009-1012.
8. Tadahiro N, Takashi M, Keizo S. Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 2000; 23:263-266.
9. Wolf AM, Wolf D, Steurer M et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9: 606-612.
10. McMillan DC, Fyffe GD, Wotherspoon HA et al. Prospective study of circulating T-lymphocyte subpopulations and disease progression in colorectal cancer. Dis Colon Rectum 1997; 40: 1068-1067.
11. Jacobson-Brown P, Neuman MG. Colon polyps and cytokines: emerging immunological mechanisms. Romanian J Gastroenterol 2003; 12: 207-214.
12. Walker CB, Bruce DM, Heys SD, Gough DB, Binnie NR, Eremin O. Minimal modulation of lymphocyte and natural killer cell subsets following minimal access surgery. Am J Surgery 1999; 177: 48-54.
13. Arista MC, Callopoli A, De Franceschi L et al. Flow cytometric study of lymphocyte subsets in patients at different stages of colorectal carcinoma. Dis Colon Rectum 1994; 37: 30-34.
14. Cho MY, Joh YG, Kim NR et al. T-lymphocyte subsets in patients with AJCC stage III gastric cancer during postoperative adjuvant chemotherapy. Scand J Surg 2002; 91: 172-177.
15. Paholyuk TD, Zacharzeva LM, Koshel KV et al. Stage of differentiation, proliferative index of tumor cells and cytotoxic activity of peripheral blood lymphocytes in colorectal cancer patients. Experim Oncol 2004; 26: 161-163.